Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K S McNaught

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Neuroscience Letters|January 4, 2001
Proteasomal function is impaired in substantia nigra in Parkinson's diseaseK S McNaught, P Jenner
Biochemical Pharmacology|September 7, 2000
Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activationK S McNaught, P Jenner
Neuroscience Letters|May 2, 2000
Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor releaseK S McNaught, P Jenner
Journal of Neurochemistry|December 3, 1999
Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-culturesK S McNaught, P Jenner
Journal of Neurochemistry|April 2, 1998
Nitric oxide causes glutamate release from brain synaptosomesK S McNaught, G C Brown
Biochemical Pharmacology|October 17, 1998
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's diseaseK S McNaught, P A Carrupt, C Altomare, et al.
Biochemical Pharmacology|September 7, 1995
Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationshipsU Thull, S Kneubühler, P Gaillard, et al.
Biochemical Pharmacology|July 12, 1996
Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineK S McNaught, U Thull, P A Carrupt, et al.
Biochemical Pharmacology|November 27, 1995
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)K S McNaught, U Thull, P A Carrupt, et al.
Neuroscience Letters|March 8, 1996
Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineK S McNaught, U Thull, P A Carrupt, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neuroscience Letters|January 4, 2001
Proteasomal function is impaired in substantia nigra in Parkinson's diseaseK S McNaught, P Jenner
Biochemical Pharmacology|September 7, 2000
Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activationK S McNaught, P Jenner
Neuroscience Letters|May 2, 2000
Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor releaseK S McNaught, P Jenner
Journal of Neurochemistry|December 3, 1999
Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-culturesK S McNaught, P Jenner
Journal of Neurochemistry|April 2, 1998
Nitric oxide causes glutamate release from brain synaptosomesK S McNaught, G C Brown
Biochemical Pharmacology|October 17, 1998
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's diseaseK S McNaught, P A Carrupt, C Altomare, et al.
Biochemical Pharmacology|September 7, 1995
Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationshipsU Thull, S Kneubühler, P Gaillard, et al.
Biochemical Pharmacology|July 12, 1996
Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineK S McNaught, U Thull, P A Carrupt, et al.
Biochemical Pharmacology|November 27, 1995
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)K S McNaught, U Thull, P A Carrupt, et al.
Neuroscience Letters|March 8, 1996
Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineK S McNaught, U Thull, P A Carrupt, et al.
Pageof 2